TC
Alaunos Therapeutics, Inc.
TCRT · NASDAQ
$1.63 -2.98% (-$0.05)
1M -18.32%
Market Cap $4.03M
P/E Ratio -
Div. Yield -
ROE 232.60%
Piotroski F-Score Weak
1/9Valuation
12 /100
Expensive P/B 6.18x
P/S 1,343.18x
PEG N/A
Growth
0 /100
Declining Book val. growth 61.78%
Rev. growth 88.04%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 94,166.60%
Op. margin 135,267.00%
Gross margin 27,833.30%
Quality
0 /100
Poor Asset turnover 0.00x
ROA 264.51%
ROIC 622.39%
Debt
74 /100
Low Current ratio 0.77x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
29 /100
Unstable Profitable years 0
EPS volatility 38.77%
Beta -0.96x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TCRT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Holger Weis
Employees
1
Headquarters
Fort Lauderdale
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report